| Product NDC: | 60258-001 |
| Proprietary Name: | Cytra-2 |
| Non Proprietary Name: | Sodium Citrate and Citric Acid |
| Active Ingredient(s): | 334; 500 mg/5mL; mg/5mL & nbsp; Sodium Citrate and Citric Acid |
| Administration Route(s): | ORAL |
| Dosage Form(s): | LIQUID |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 60258-001 |
| Labeler Name: | Cypress Pharmaceutical, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | |
| Marketing Category: | UNAPPROVED DRUG OTHER |
| Start Marketing Date: | 20081001 |
| Package NDC: | 60258-001-16 |
| Package Description: | 473 mL in 1 BOTTLE, PLASTIC (60258-001-16) |
| NDC Code | 60258-001-16 |
| Proprietary Name | Cytra-2 |
| Package Description | 473 mL in 1 BOTTLE, PLASTIC (60258-001-16) |
| Product NDC | 60258-001 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Sodium Citrate and Citric Acid |
| Dosage Form Name | LIQUID |
| Route Name | ORAL |
| Start Marketing Date | 20081001 |
| Marketing Category Name | UNAPPROVED DRUG OTHER |
| Labeler Name | Cypress Pharmaceutical, Inc. |
| Substance Name | CITRIC ACID MONOHYDRATE; TRISODIUM CITRATE DIHYDRATE |
| Strength Number | 334; 500 |
| Strength Unit | mg/5mL; mg/5mL |
| Pharmaceutical Classes |